FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4200381727> ?p ?o ?g. }

• W4200381727 abstract "Although microbioa-based therapies have shown putative effects on the treatment of non-alcoholic fatty liver disease (NAFLD), it is not clear how microbiota-derived metabolites contribute to the prevention of NAFLD. We explored the metabolomic signature of Lactobacillus lactis and Pediococcus pentosaceus in NAFLD mice and its association in NAFLD patients.We used Western diet-induced NAFLD mice, and L. lactis and P. pentosaceus were administered to animals in the drinking water at a concentration of 109 CFU/g for 8 weeks. NAFLD severity was determined based on liver/body weight, pathology and biochemistry markers. Caecal samples were collected for the metagenomics by 16S rRNA sequencing. Metabolite profiles were obtained from caecum, liver and serum. Human stool samples (healthy control [n = 22] and NAFLD patients [n = 23]) were collected to investigate clinical reproducibility for microbiota-derived metabolites signature and metabolomics biomarker.L. lactis and P. pentosaceus supplementation effectively normalized weight ratio, NAFLD activity score, biochemical markers, cytokines and gut-tight junction. While faecal microbiota varied according to the different treatments, key metabolic features including short chain fatty acids (SCFAs), bile acids (BAs) and tryptophan metabolites were analogously restored by both probiotic supplementations. The protective effects of indole compounds were validated with in vitro and in vivo models, including anti-inflammatory effects. The metabolomic signatures were replicated in NAFLD patients, accompanied by the comparable levels of Firmicutes/Bacteroidetes ratio, which was significantly higher (4.3) compared with control (0.6). Besides, the consequent biomarker panel with six stool metabolites (indole, BAs, and SCFAs) showed 0.922 (area under the curve) in the diagnosis of NAFLD.NAFLD progression was robustly associated with metabolic dys-regulations in the SCFAs, bile acid and indole compounds, and NAFLD can be accurately diagnosed using the metabolites. L. lactis and P. pentosaceus ameliorate NAFLD progression by modulating gut metagenomic and metabolic environment, particularly tryptophan pathway, of the gut-liver axis." @default.
• W4200381727 created "2021-12-31" @default.
• W4200381727 creator A5018039278 @default.
• W4200381727 creator A5019174635 @default.
• W4200381727 creator A5020267877 @default.
• W4200381727 creator A5024304363 @default.
• W4200381727 creator A5026548883 @default.
• W4200381727 creator A5030114844 @default.
• W4200381727 creator A5030480121 @default.
• W4200381727 creator A5032946485 @default.
• W4200381727 creator A5034709148 @default.
• W4200381727 creator A5036007898 @default.
• W4200381727 creator A5040183070 @default.
• W4200381727 creator A5040550808 @default.
• W4200381727 creator A5049620316 @default.
• W4200381727 creator A5053606356 @default.
• W4200381727 creator A5060219831 @default.
• W4200381727 creator A5061984612 @default.
• W4200381727 creator A5063974289 @default.
• W4200381727 creator A5073485901 @default.
• W4200381727 creator A5077038657 @default.
• W4200381727 creator A5077800857 @default.
• W4200381727 creator A5080127932 @default.
• W4200381727 creator A5086078079 @default.
• W4200381727 date "2021-12-01" @default.
• W4200381727 modified "2023-10-16" @default.
• W4200381727 title "<i>Lactobacillus lactis</i> and <i>Pediococcus pentosaceus</i> ‐driven reprogramming of gut microbiome and metabolome ameliorates the progression of non‐alcoholic fatty liver disease" @default.
• W4200381727 cites W1948266836 @default.
• W4200381727 cites W1964944200 @default.
• W4200381727 cites W2019402080 @default.
• W4200381727 cites W2029730391 @default.
• W4200381727 cites W2030672139 @default.
• W4200381727 cites W2038554929 @default.
• W4200381727 cites W2058300873 @default.
• W4200381727 cites W2062812115 @default.
• W4200381727 cites W2064076022 @default.
• W4200381727 cites W2088166607 @default.
• W4200381727 cites W2091089364 @default.
• W4200381727 cites W2124351063 @default.
• W4200381727 cites W2151798187 @default.
• W4200381727 cites W2159675211 @default.
• W4200381727 cites W2247868881 @default.
• W4200381727 cites W2276368330 @default.
• W4200381727 cites W2329062174 @default.
• W4200381727 cites W2409656339 @default.
• W4200381727 cites W2483891712 @default.
• W4200381727 cites W2511466266 @default.
• W4200381727 cites W2568515092 @default.
• W4200381727 cites W2614935527 @default.
• W4200381727 cites W2618286674 @default.
• W4200381727 cites W2735584664 @default.
• W4200381727 cites W2761145411 @default.
• W4200381727 cites W2767683865 @default.
• W4200381727 cites W2785412044 @default.
• W4200381727 cites W2802744456 @default.
• W4200381727 cites W2803664483 @default.
• W4200381727 cites W2809982649 @default.
• W4200381727 cites W2884267073 @default.
• W4200381727 cites W2884742993 @default.
• W4200381727 cites W2886282415 @default.
• W4200381727 cites W2887143051 @default.
• W4200381727 cites W2888016714 @default.
• W4200381727 cites W2889715773 @default.
• W4200381727 cites W2894856581 @default.
• W4200381727 cites W2900216482 @default.
• W4200381727 cites W2900460205 @default.
• W4200381727 cites W2910159017 @default.
• W4200381727 cites W2911517211 @default.
• W4200381727 cites W2914699377 @default.
• W4200381727 cites W2920891429 @default.
• W4200381727 cites W2922620113 @default.
• W4200381727 cites W2944184554 @default.
• W4200381727 cites W2972533507 @default.
• W4200381727 cites W3002140639 @default.
• W4200381727 cites W3006193147 @default.
• W4200381727 cites W3006645071 @default.
• W4200381727 cites W3007936066 @default.
• W4200381727 cites W3011166092 @default.
• W4200381727 cites W3015861324 @default.
• W4200381727 cites W3089718558 @default.
• W4200381727 cites W3129369845 @default.
• W4200381727 doi "https://doi.org/10.1002/ctm2.634" @default.
• W4200381727 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34965016" @default.
• W4200381727 hasPublicationYear "2021" @default.
• W4200381727 type Work @default.
• W4200381727 citedByCount "37" @default.
• W4200381727 countsByYear W42003817272022 @default.
• W4200381727 countsByYear W42003817272023 @default.
• W4200381727 crossrefType "journal-article" @default.
• W4200381727 hasAuthorship W4200381727A5018039278 @default.
• W4200381727 hasAuthorship W4200381727A5019174635 @default.
• W4200381727 hasAuthorship W4200381727A5020267877 @default.
• W4200381727 hasAuthorship W4200381727A5024304363 @default.
• W4200381727 hasAuthorship W4200381727A5026548883 @default.
• W4200381727 hasAuthorship W4200381727A5030114844 @default.
• W4200381727 hasAuthorship W4200381727A5030480121 @default.
• W4200381727 hasAuthorship W4200381727A5032946485 @default.
• W4200381727 hasAuthorship W4200381727A5034709148 @default.
• W4200381727 hasAuthorship W4200381727A5036007898 @default.
• W4200381727 hasAuthorship W4200381727A5040183070 @default.

• next